stockrowiRhythm Holdings, Inc.
IRTC Healthcare Medical Devices
iRhythm Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747.1 million, up 26.2% from fiscal 2024.
- Revenue
- +14.9%
- EPS
- −462.5%
- Free cash flow
- −157.6%
- Total debt
- +0.48%
Quarter to September 2026, against a year earlier
Follow IRTC
Alert me
iRhythm Holdings, Inc. (IRTC) Net income
iRhythm Holdings, Inc.'s net income for fiscal 2025 was −$44.6M, compared with −$113.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$38.6M. Over the past ten years it has ranged from −$123.4M (fiscal 2023) to −$20.9M (fiscal 2016); the current reading is higher than 64% of that period. iRhythm Holdings, Inc. ranks 107th of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$44.6M | — |
| FY2024 | −$113.3M | — |
| FY2023 | −$123.4M | — |
| FY2022 | −$116.2M | — |
| FY2021 | −$101.4M | — |
| FY2020 | −$43.8M | — |
| FY2019 | −$54.6M | — |
| FY2018 | −$50.4M | — |
| FY2017 | −$29.7M | — |
| FY2016 | −$20.9M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | −$29.9M | — |
| Jun 2026 | −$381.0K | — |
| Mar 2026 | −$13.9M | — |
| Dec 2025 | $5.6M | — |
| 42 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| LIVN LivaNova PLC compare | $196.1M |
| TMDX TransMedics Group, Inc. compare | $144.5M |
| HAE Haemonetics Corporation compare | $103.9M |
| ITGR Integer Holdings Corporation compare | $103.7M |
| UFPT UFP Technologies, Inc. compare | $72.3M |
| AXGN AxoGen, Inc. compare | −$31.9M |
| IRTC iRhythm Holdings, Inc. | −$38.6M |
| NEOG Neogen Corporation compare | −$56.1M |
| TXG 10x Genomics compare | −$75.1M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on IRTC
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement